Physician profile
Christopher C Scott
NPI 1720266307
$2,185.96
in general payments reported to CMS, 2019-2025
28 companies · $510 in 2025
The $510 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $139 · 2021: $32.32 · 2022: $252 · 2023: $399 · 2024: $246 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carbofix Orthopedics INC | $409.47 | 2022-2024 | |
| Acumed LLC | $207.50 | 2023-2025 | Acumed, Acumed |
| Vertex Pharmaceuticals Incorporated | $199.53 | 2024-2025 | |
| Fx Shoulder Solutions, INC | $197.04 | 2019 | |
| Horizon Therapeutics Plc | $169.81 | 2019-2022 | |
| Medartis INC. | $150.00 | 2022 | |
| Medical Device Business Services, INC. | $109.52 | 2019 | |
| Pacira Therapeutics, INC. | $95.55 | 2019-2021 | |
| United Orthopedics LLC | $82.86 | 2024 | |
| Depuy Synthes Sales INC. | $70.31 | 2025 | Va-Lcp |
| Corin USA | $66.93 | 2019 | |
| Smith+Nephew, INC. | $46.38 | 2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Kci USA, INC. | $45.93 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $40.58 | 2022-2023 | Dysport |
| Bioventus LLC | $31.30 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $25.79 | 2024 | |
| Omnilife Science, INC | $25.66 | 2022 | |
| Medtronic USA, INC. | $23.58 | 2019 | |
| Baxter Healthcare | $22.90 | 2025 | Perclot |
| Innovation Technologies INC | $22.68 | 2024 | Irrisept |
| Access Pro Medical, LLC | $20.88 | 2025 | Matriderm |
| Sanara Medtech INC. | $20.17 | 2024 | Celleraterx |
| Daiichi Sankyo INC. | $20.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $18.47 | 2020 | |
| Grt US Holding, INC. | $17.41 | 2022 | |
| Aroa Biosurgery Incorporated | $16.73 | 2024 | |
| Fidia Pharma USA INC. | $14.66 | 2019 | |
| Hydrocision, INC. | $14.32 | 2023 | Tenjet |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.